<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">pharmjournal</journal-id><journal-title-group><journal-title xml:lang="ru">Разработка и регистрация лекарственных средств</journal-title><trans-title-group xml:lang="en"><trans-title>Drug development &amp; registration</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2305-2066</issn><issn pub-type="epub">2658-5049</issn><publisher><publisher-name>LLC «CPHA»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.33380/2305-2066-2024-13-4-1951</article-id><article-id custom-type="elpub" pub-id-type="custom">pharmjournal-1961</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ФАРМАЦЕВТИЧЕСКАЯ ТЕХНОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PHARMACEUTICAL TECHNOLOGY</subject></subj-group></article-categories><title-group><article-title>Твердые дисперсные системы как способ создания лекарственных форм с замедленным высвобождением из расплывающихся субстанций</article-title><trans-title-group xml:lang="en"><trans-title>Production sustained release dosage forms from deliquescent substances by solid dispersion systems</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6391-2689</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Терентьева</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Terenteva</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>197022, г. Санкт-Петербург, ул. Профессора Попова, 14, литера А</p></bio><bio xml:lang="en"><p>14A, Prof. Popova str., Saint-Petersburg, 197022</p></bio><email xlink:type="simple">oksana.terentyeva@pharminnotech.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9292-4240</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Коцур</surname><given-names>Ю. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Kotsur</surname><given-names>Yu. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>197022, г. Санкт-Петербург, ул. Профессора Попова, 14, литера А</p></bio><bio xml:lang="en"><p>14A, Prof. Popova str., Saint-Petersburg, 197022</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5483-6626</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Наркевич</surname><given-names>И. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Narkevich</surname><given-names>I. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>197022, г. Санкт-Петербург, ул. Профессора Попова, 14, литера А</p></bio><bio xml:lang="en"><p>14A, Prof. Popova str., Saint-Petersburg, 197022</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8077-2462</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Флисюк</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Flisyuk</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>197022, г. Санкт-Петербург, ул. Профессора Попова, 14, литера А</p></bio><bio xml:lang="en"><p>14A, Prof. Popova str., Saint-Petersburg, 197022</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Санкт-Петербургский государственный химико-фармацевтический университет» Министерства здравоохранения Российской Федерации (ФГБОУ ВО СПХФУ Минздрава России)</institution></aff><aff xml:lang="en"><institution>Saint-Petersburg State Chemical and Pharmaceutical University</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>01</day><month>11</month><year>2024</year></pub-date><volume>13</volume><issue>4</issue><fpage>99</fpage><lpage>106</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Терентьева О.А., Коцур Ю.М., Наркевич И.А., Флисюк Е.В., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Терентьева О.А., Коцур Ю.М., Наркевич И.А., Флисюк Е.В.</copyright-holder><copyright-holder xml:lang="en">Terenteva O.A., Kotsur Y.M., Narkevich I.A., Flisyuk E.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pharmjournal.ru/jour/article/view/1961">https://www.pharmjournal.ru/jour/article/view/1961</self-uri><abstract><sec><title>Введение</title><p>Введение. Создание твердых лекарственных форм из гигроскопичных субстанций является сложной технологической задачей. Введение гигроскопичных веществ в полимерную матрицу позволяет снизить их влагосорбционную способность.</p></sec><sec><title>Цель</title><p>Цель. Оценить пригодность термопластичных полимеров для создания твердых дисперсий с расплывающейся субстанцией с целью снижения гигроскопичности субстанции и получения твердых дозированных лекарственных форм с замедленными высвобождением.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Субстанция: бис{2-[(2Z)-4-гидрокси-4-оксобут-2-еноилокси]-N,N-диэтилэтанаминия} бутандионат (ДЭАЭ); вспомогательные вещества: Kollidon® VA 64, Soluplus®, полиэтиленгликоль марок 1500, 6000, 8000, полоксамеры Kolliphor® P 188 и Kolliphor® P 407; реактивы: хлористоводородная кислота, натрия дигидрофосфат, калия гидрофосфат. Расплав компонентов получали на двухшнековом лабораторном экструдере и отливали в силиконовые формы. Полученные твердые лекарственные формы исследовали по показателю «распадаемость» в трех средах, соответствующих отделам ЖКТ человека.</p></sec><sec><title>Результаты и обсуждение</title><p>Результаты и обсуждение. Субстанция ДЭАЭ характеризуется как расплывающаяся. Введение ДЭАЭ в полимерные матрицы на основе ПЭГ и его сополимеров позволило снизить гигроскопичность готовых лекарственных форм в виде плиток. Введение в расплав солюбилизаторов позволило получить плитки с надлежащими органолептическими свойствами. Высвобождение ДЭАЭ из плиток в виде медведя или тороида происходит в среднем на 29–47 % быстрее, чем из плиток в виде сердца.</p></sec><sec><title>Заключение</title><p>Заключение. Перспективными для дальнейшей разработки плиток, содержащих ДЭАЭ, оказались составы на основе Soluplus® и Kolliphor® P 407. С целью создания плиток с замедленным высвобождением рекомендуется использовать формы в виде сердечек, так как у них меньше площадь поверхности.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. The production of solid dosage forms from hygroscopic substances is a complex technological task. The addition of hygroscopic substances into a polymer matrix allows to reduce their moisture absorption capacity.</p></sec><sec><title>Aim</title><p>Aim. Reducing the hygroscopicity of deliquescent substances and obtaining sustained release solid dosage forms by using solid dispersion systems.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. Substance: DEAE; excipients: Kollidon® VA 64, Soluplus®, PEG 1500, PEG 6000, PEG 8000, Poloxamer Kolliphor® P 188 and Kolliphor® P 407; reagents: hydrochloric acid, sodium dihydrogen phosphate, potassium hydrogen phosphate. The melt of the components was obtained on a twin-screw laboratory extruder and cast into silicone molds. The resulting solid dosage forms were studied for disintegration in three environments corresponding to the sections of the human gastrointestinal tract.</p></sec><sec><title>Results and discussion</title><p>Results and discussion. The active pharmaceutical substance DEAE is characterized as deliquescent substance. The introduction of DEAE into PEG-polymer matrices made it possible to reduce the hygroscopicity of solid dosage forms in the form of bars. The introduction of solubilizers into the melt made it possible to obtain bars with the appropriate organoleptic properties. The release of DEAE from bear- or toroid-shaped bars occurs on average 29–47 % faster than from heart-shaped bars.</p></sec><sec><title>Conclusion</title><p>Conclusion. Compositions based on Soluplus® and Kolliphor® P 407 have proven promising for further development of tiles containing DEAE. In order to create tiles with a slow release, it is recommended to use heart-shaped forms, as they have a smaller surface area.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>экструзия расплава</kwd><kwd>гигроскопичность</kwd><kwd>формовка</kwd><kwd>распадаемость</kwd><kwd>нейропротектор</kwd></kwd-group><kwd-group xml:lang="en"><kwd>hot melt extrusion</kwd><kwd>hygroscopicity</kwd><kwd>molding</kwd><kwd>disintegration</kwd><kwd>neuroprotector</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Dhondale M. R., Thakor P., Nambiar A. G., Singh M., Agrawal A. K., Shastri N.R., Kumar D. Co-Crystallization Approach to Enhance the Stability of Moisture-Sensitive Drugs. Pharmaceutics. 2023;15(1):189. DOI: 10.3390/pharmaceutics15010189.</mixed-citation><mixed-citation xml:lang="en">Dhondale M. R., Thakor P., Nambiar A. G., Singh M., Agrawal A. K., Shastri N.R., Kumar D. Co-Crystallization Approach to Enhance the Stability of Moisture-Sensitive Drugs. Pharmaceutics. 2023;15(1):189. DOI: 10.3390/pharmaceutics15010189.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Rajabi-Siahboomi A. R., Levina M., Upadhye S. B., Teckoe J. Excipient Selection in Oral Solid Dosage Formulations Containing Moisture Sensitive Drugs. Excipient Applications in Formulation Design and Drug Delivery. 2015;385–421. DOI: 10.1007/978-3-319-20206-8_13.</mixed-citation><mixed-citation xml:lang="en">Rajabi-Siahboomi A. R., Levina M., Upadhye S. B., Teckoe J. Excipient Selection in Oral Solid Dosage Formulations Containing Moisture Sensitive Drugs. Excipient Applications in Formulation Design and Drug Delivery. 2015;385–421. DOI: 10.1007/978-3-319-20206-8_13.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Fu Z.-Z., Yao Y.‐H., Guo S.‐J., Wang K., Zhang Q., Fu Q. Effect of Plasticization on Stretching Stability of Poly(Vinyl Alcohol) Films: A Case Study Using Glycerol and Water. Macromolecular Rapid Communications. 2023;44(1):e2200296. DOI: 10.1002/marc.202200296.</mixed-citation><mixed-citation xml:lang="en">Fu Z.-Z., Yao Y.‐H., Guo S.‐J., Wang K., Zhang Q., Fu Q. Effect of Plasticization on Stretching Stability of Poly(Vinyl Alcohol) Films: A Case Study Using Glycerol and Water. Macromolecular Rapid Communications. 2023;44(1):e2200296. DOI: 10.1002/marc.202200296.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Kumari L., Choudhari Y., Patel P., Das Gupta G., Singh D., Rosenholm J.M., Kumar Bansal K., Das Kurmi B. Advancement in Solubilization Approaches: A Step towards Bioavailability Enhancement of Poorly Soluble Drugs. Life. 2023;13(5):1099. DOI: 10.3390/life13051099.</mixed-citation><mixed-citation xml:lang="en">Kumari L., Choudhari Y., Patel P., Das Gupta G., Singh D., Rosenholm J.M., Kumar Bansal K., Das Kurmi B. Advancement in Solubilization Approaches: A Step towards Bioavailability Enhancement of Poorly Soluble Drugs. Life. 2023;13(5):1099. DOI: 10.3390/life13051099.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Newman A. W., Reutzel-Edens S. M., Zografi G. Characterization of the "hygroscopic" properties of active pharmaceutical ingredients. Journal of Pharmaceutical Sciences. 2008;97(3):1047–1059. DOI: 10.1002/jps.21033.</mixed-citation><mixed-citation xml:lang="en">Newman A. W., Reutzel-Edens S. M., Zografi G. Characterization of the "hygroscopic" properties of active pharmaceutical ingredients. Journal of Pharmaceutical Sciences. 2008;97(3):1047–1059. DOI: 10.1002/jps.21033.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Thakur T. S., Thakuria R. Crystalline Multicomponent Solids: An Alternative for Addressing the Hygroscopicity Issue in Pharmaceutical Materials. Crystal Growth &amp; Design. 2020;20(9):6245–6265. DOI: 10.1021/acs.cgd.0c00654.</mixed-citation><mixed-citation xml:lang="en">Thakur T. S., Thakuria R. Crystalline Multicomponent Solids: An Alternative for Addressing the Hygroscopicity Issue in Pharmaceutical Materials. Crystal Growth &amp; Design. 2020;20(9):6245–6265. DOI: 10.1021/acs.cgd.0c00654.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Cheow W. S., Kiew T. Y., Hadinoto K. Combining inkjet printing and amorphous nanonization to prepare personalized dosage forms of poorly-soluble drugs. European Journal of Pharmaceutics and Biopharmaceutics. 2015;96:314–321. DOI: 10.1016/j.ejpb.2015.08.012.</mixed-citation><mixed-citation xml:lang="en">Cheow W. S., Kiew T. Y., Hadinoto K. Combining inkjet printing and amorphous nanonization to prepare personalized dosage forms of poorly-soluble drugs. European Journal of Pharmaceutics and Biopharmaceutics. 2015;96:314–321. DOI: 10.1016/j.ejpb.2015.08.012.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Emery E., Oliver J., Pugsley T., Sharma J., Zhou J. Flowability of moist pharmaceutical powders. Powder Technology. 2009;189(3):409–415. DOI: 10.1016/j.powtec.2008.06.017.</mixed-citation><mixed-citation xml:lang="en">Emery E., Oliver J., Pugsley T., Sharma J., Zhou J. Flowability of moist pharmaceutical powders. Powder Technology. 2009;189(3):409–415. DOI: 10.1016/j.powtec.2008.06.017.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Terenteva O. A., Vainshtein V. A., Flisyuk E. V., Generalova Yu. E. Tablet Development for a Hydroscopic Drug Using Solid Dispersion. Drug development &amp; registration. 2020;9(1):23–28. (In Russ.) DOI: 10.33380/2305-2066-2020-9-1-23-28.</mixed-citation><mixed-citation xml:lang="en">Terenteva O. A., Vainshtein V. A., Flisyuk E. V., Generalova Yu. E. Tablet Development for a Hydroscopic Drug Using Solid Dispersion. Drug development &amp; registration. 2020;9(1):23–28. (In Russ.) DOI: 10.33380/2305-2066-2020-9-1-23-28.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Ng L. H., Ling J. K. U., Hadinoto K. Formulation Strategies to Improve the Stability and Handling of Oral Solid Dosage Forms of Highly Hygroscopic Pharmaceuticals and Nutraceuticals. Pharmaceutics. 2022;14(10):2015. DOI: 10.3390/pharmaceutics14102015.</mixed-citation><mixed-citation xml:lang="en">Ng L. H., Ling J. K. U., Hadinoto K. Formulation Strategies to Improve the Stability and Handling of Oral Solid Dosage Forms of Highly Hygroscopic Pharmaceuticals and Nutraceuticals. Pharmaceutics. 2022;14(10):2015. DOI: 10.3390/pharmaceutics14102015.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Kolter K., Karl M., Gryczke A. Hot-melt extrusion with BASF pharma polymers. 2 nd edition. 2012. 201 p.</mixed-citation><mixed-citation xml:lang="en">Kolter K., Karl M., Gryczke A. Hot-melt extrusion with BASF pharma polymers. 2 nd edition. 2012. 201 p.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Terenteva O. A., Gusev K. A., Tikhonova V. V., Maimistov D. N., Shandryuk G. A., Flisyuk E. V. Three-dimensional printing of ramipril tablets by fused deposition modeling. Drug development &amp; registration. 2021;10(4):79–87. (In Russ.) DOI: 10.33380/2305-2066-2021-10-4(1)-79-87.</mixed-citation><mixed-citation xml:lang="en">Terenteva O. A., Gusev K. A., Tikhonova V. V., Maimistov D. N., Shandryuk G. A., Flisyuk E. V. Three-dimensional printing of ramipril tablets by fused deposition modeling. Drug development &amp; registration. 2021;10(4):79–87. (In Russ.) DOI: 10.33380/2305-2066-2021-10-4(1)-79-87.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
